Author:
Slade Eric,Berg Laura,Dworzynski Katharina,Manchanda Ranjit
Reference13 articles.
1. National Institute for Health and Care Excellence. Final guideline scope Ovarian cancer: identifying and managing familial and genetic risk 2023. https://www.nice.org.uk/guidance/ng241/history
2. Current detection rates and time-to-detection of all identifiable BRCA carriers in the Greater London population
3. Specialist oncological surgery for removal of the ovaries and fallopian tubes in
BRCA1
and
BRCA2
pathogenic variant carriers may reduce primary peritoneal cancer risk to very low levels
4. National Institute for Health and Care Excellence. Ovarian cancer: identifying and managing familial and genetic risk (NICE guideline NG10225). 2024. https://www.nice.org.uk/guidance/ng241
5. National Institute for Health and Care Excellence. Ovarian cancer: recognition and initial management (clinical guideline CG122). 2011. https://www.nice.org.uk/guidance/cg122
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献